Pharmacological Therapy of Atrial Fibrillation and Flutter: Advances and Limitations of Specific Antiarrhythmic Drugs
Reference15 articles.
1. Hohnloser SH, Kuck KH, Lilienthal J (2000) Rhythm or rate control in atrial fibrillation. Pharmacological intervention in atrial fibrillation (PIAF): a randomized trial. Lancet 356:1789–1794
2. Kühlkamp V, Schirdewan A, Stangl K, Homberg M, Flock M, Beck OA (2000) Use of metoprolol CR/XL to maintain sinus rhythm after conversion from persistent atrial fibrillation. A randomized, double-blind, placebo-controlled study. J Am Coll Cardiol 36:139–146
3. Roden DM, Woosley RL, Primm RK (1986) Incidence and clinical features of the quinidine associated long QT syndrome. Implications for patient care. Am Heart J 111:1088–1093
4. CAST Investigators (1989) Effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 321:406–412
5. Hohnloser SH, Zabel M (1992) Short-and long-term efficacy and safety of flecainide acetate for supraventricular arrhythmias. Am J Cardiol 70:3–10